G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 96 filers reported holding G1 THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $49,646,000 | +63.3% | 949,431 | +35.7% | 1.33% | +156.2% |
| Q2 2018 | $30,397,000 | +17.3% | 699,431 | 0.0% | 0.52% | +13.3% |
| Q1 2018 | $25,914,000 | +190.3% | 699,431 | +55.4% | 0.46% | +200.7% |
| Q4 2017 | $8,928,000 | -20.3% | 450,000 | 0.0% | 0.15% | -17.8% |
| Q3 2017 | $11,201,000 | +42.7% | 450,000 | 0.0% | 0.18% | +52.9% |
| Q2 2017 | $7,848,000 | – | 450,000 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 650,000 | $3,529,500 | 0.92% |
| CHI Advisors LLC | 333,945 | $1,813,321 | 0.48% |
| PVG ASSET MANAGEMENT CORP | 15,585 | $84,626 | 0.37% |
| Rhenman & Partners Asset Management AB | 370,000 | $2,009,100 | 0.21% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 184,000 | $999,120 | 0.18% |
| Birchview Capital, LP | 40,000 | $217 | 0.15% |
| XTX Topco Ltd | 102,282 | $555,391 | 0.12% |
| Tekla Capital Management LLC | 423,869 | $2,301,609 | 0.09% |
| Woodline Partners LP | 1,028,967 | $5,587,291 | 0.08% |
| Curi Wealth Management, LLC | 81,009 | $439,879 | 0.06% |